Birdwatch Note
2022-09-05 13:29:45 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This is highly misleading. The article linked to at the NIH recommends against the use of ivermectin as a treatment for COVID-19 as it is proven to be ineffective. “The Panel recommends against the use of ivermectin for the treatment of COVID-19” https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Written by 8BFAD8285CAFFD31C0DBA633F2C52E42
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1565148577952894978
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1566780628661669889
- noteId - 1566780628661669889
- participantId - 8BFAD8285CAFFD31C0DBA633F2C52E42
- noteAuthorParticipantId -
- createdAtMillis - 1662384585906
- tweetId - 1565148577952894978
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This is highly misleading. The article linked to at the NIH recommends against the use of ivermectin as a treatment for COVID-19 as it is proven to be ineffective. “The Panel recommends against the use of ivermectin for the treatment of COVID-19” https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2022-09-05 13:29:45 UTC (1662384585906) |
2022-09-27 17:14:23 UTC (1664298863750) |
CURRENTLY_RATED_HELPFUL | 2022-09-27 17:14:23 UTC (1664298863750) |
NEEDS_MORE_RATINGS | 2022-09-27 17:14:23 UTC (1664298863750) |
CURRENTLY_RATED_HELPFUL | 80B440D82AFDE0B37332323C1A5E2FE37D810CDCF0CC78D348D1E1237BA2CE8F |
| 2022-09-05 13:29:45 UTC (1662384585906) |
2022-09-27 17:14:23 UTC (1664298863750) |
CURRENTLY_RATED_HELPFUL | 2022-09-27 17:14:23 UTC (1664298863750) |
NEEDS_MORE_RATINGS | 2022-09-27 17:14:23 UTC (1664298863750) |
CURRENTLY_RATED_HELPFUL | 8BFAD8285CAFFD31C0DBA633F2C52E42 |
Note Ratings
| rated at | rated by | |
| 2022-09-05 21:06:05 -0500 | 0970AF2EDBB2160765D64BA2ADD89F73D654E9F9EC01C4671E82A8F98561183F | Rating Details |
| 2022-09-05 10:11:27 -0500 | 0A98F8DF5EDD42D0073EF5CBFAC32E6B41A3478D6689D5D7B6D72C74F37A2836 | Rating Details |
| 2022-09-05 18:21:11 -0500 | 0AB689C453F1E569091558B03440721F | Rating Details |
| 2022-09-05 10:13:40 -0500 | 0C04AD8FB099DAEB90EFA144689685242F1A64BB5394EA1972E7060A1DA42060 | Rating Details |
| 2022-09-05 09:46:14 -0500 | 0C91900F7892D8DA899BB85193A8758A | Rating Details |
| 2022-09-05 08:46:59 -0500 | 1E9D60C6D4AE0895E007C4F746149AED | Rating Details |
| 2022-09-06 08:22:06 -0500 | 2704985249CBA3C402DD3BA1E5272684 | Rating Details |
| 2022-09-05 18:21:11 -0500 | 40207DE86D2E8AD9FD85726281BA80AEBBDF045DC3DC40942C20C778DB8DF934 | Rating Details |
| 2022-09-05 17:32:56 -0500 | 46B1BAE53715CEAF4CA597E32756C909DC643458B563C8B849DC566AB992B5C3 | Rating Details |
| 2022-09-05 12:44:55 -0500 | 46D893DFC474111C12B5EF54ADED5291021E07B5BC4D944EB4F35D18A93785C7 | Rating Details |
| 2022-09-06 18:51:11 -0500 | 491F86E495D57AD373CE546FA4D9E4C79AB3B56F4BD9907D2CD96BB4578540B1 | Rating Details |
| 2022-09-05 08:40:47 -0500 | 4D971DD119DA920463DF54524736E0A6 | Rating Details |
| 2022-09-05 17:44:55 -0500 | 51CF24E741A18508E181F80408E6E7E109FDDE98B31A9F11F05480731FF485A6 | Rating Details |
| 2022-09-05 08:46:59 -0500 | 55CDB0C1B5A58436987B00C63EBDD3980BF71CC3A30D4EE3BD4BA7D33AAEBCAD | Rating Details |
| 2022-09-05 17:44:55 -0500 | 5AD0B5581E4AC4683F4A8D75DEB62680 | Rating Details |
| 2022-09-05 10:53:50 -0500 | 6C4D39819380C974F26A34B6C85405BD | Rating Details |
| 2022-09-05 08:40:47 -0500 | 6D52E77119FC0A73F40D1C068C5E67531E16FA62CA9EF821895346168DDF9704 | Rating Details |
| 2022-09-06 08:22:06 -0500 | 73B0530E1591AC3109F75533641774F87EA2E35610AE550E4E526EFEE63D45FA | Rating Details |
| 2022-09-05 11:39:42 -0500 | 75DE5091E62053B99DD7EBEBFF9749047814415565DFD373C77AA987F69444BC | Rating Details |
| 2022-09-05 19:58:24 -0500 | 7EDA3904E35101EAF8BD30717C6CDEAF | Rating Details |
| 2022-09-05 08:54:13 -0500 | 82007165EB2C9DCD184B798192E4CD683CAE0A4CBFEDD35E0E50CDCF6CFA9F86 | Rating Details |
| 2022-09-05 10:13:40 -0500 | 826C6F8B03089518A026B94BE6E4820C | Rating Details |
| 2022-09-05 11:39:42 -0500 | 84656258148090979F23255CE507BE9C | Rating Details |
| 2022-09-05 18:21:11 -0500 | 8584AA58BA77CF8B37AF6D0B1ECAF4C9 | Rating Details |
| 2022-09-05 18:33:16 -0500 | 9439A1BE03E471B9F7026843AC7E7A4E | Rating Details |
| 2022-09-05 17:32:56 -0500 | 98280092531BA792D8E3166B34320765 | Rating Details |
| 2022-09-05 19:58:24 -0500 | 994AD3ED674F42BEDE118612F7645BBF859B14F7FB531557A19201DF41523DBD | Rating Details |
| 2022-09-05 10:53:50 -0500 | 9FDF9893DFAB4D45202E6558FAE3342DA24DFA5D58A9F7C14A2CF2DD79A3E176 | Rating Details |
| 2022-09-05 09:46:14 -0500 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
| 2022-09-05 18:21:11 -0500 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
| 2022-09-05 21:06:05 -0500 | A87524982D71DEDE3399EB34174E1E0A | Rating Details |
| 2022-09-05 13:38:15 -0500 | AD8DC42A0C7729F56C4F30E56E6262C5285C3CADAB680599CAF1924DEA605484 | Rating Details |
| 2022-09-05 08:54:13 -0500 | B3A53C09F6E8D94DDFF4850208FCE14F | Rating Details |
| 2022-09-05 18:33:16 -0500 | B58FC591E8C96DE13676245FFD327D1A6F48B39F0D4D0298B1C0B07D02B268FD | Rating Details |
| 2022-09-05 10:11:27 -0500 | CD08C16BC8791D33E6EC9C8B27C91241 | Rating Details |
| 2022-09-06 18:51:11 -0500 | CD9D49DCCCDDE369B34482B66E49E224 | Rating Details |
| 2022-09-05 12:44:55 -0500 | DB835EE09E208271F1AE42AA00D8490D | Rating Details |
| 2022-12-20 12:44:42 -0600 | DD3E036E8E736BB27D818A322EA9DDEE9954DE0A21F38CE170E423D689A209A4 | Rating Details |
| 2022-09-05 13:38:15 -0500 | DD716E5B0E50F0E1F626CD180E126B89 | Rating Details |
| 2022-09-05 12:11:03 -0500 | F092EA4CB202B72F79AC43DE5CAF2DC7D60778EB0698DDEA8AB3EED4323C2245 | Rating Details |
| 2022-09-06 01:15:09 -0500 | F7A4FC95E7E28A832C3C4564C2F9FAB3 | Rating Details |
| 2022-09-06 01:15:09 -0500 | F9C81045EEB52DA14526E5476ED03D7E98BA35B1A88FC1BEF9745C002EA8B37E | Rating Details |
| 2022-09-05 12:11:03 -0500 | FBD4C539ADDD48521B69767302DD70B1 | Rating Details |
| 2022-09-05 12:44:55 -0500 | Rating Details | |
| 2022-09-05 18:21:11 -0500 | Rating Details | |
| 2022-09-06 01:15:09 -0500 | Rating Details | |
| 2022-09-05 19:58:24 -0500 | Rating Details | |
| 2022-09-05 18:33:16 -0500 | Rating Details | |
| 2022-09-05 18:21:11 -0500 | Rating Details | |
| 2022-09-05 08:40:47 -0500 | Rating Details | |
| 2022-09-06 08:22:06 -0500 | Rating Details | |
| 2022-09-06 18:51:11 -0500 | Rating Details | |
| 2022-09-05 17:32:56 -0500 | Rating Details | |
| 2022-09-05 10:53:50 -0500 | Rating Details | |
| 2022-12-20 12:44:42 -0600 | Rating Details | |
| 2022-09-05 08:54:13 -0500 | Rating Details | |
| 2022-09-05 13:38:15 -0500 | Rating Details | |
| 2022-09-05 10:11:27 -0500 | Rating Details | |
| 2022-09-05 09:46:14 -0500 | Rating Details | |
| 2022-09-05 10:13:40 -0500 | Rating Details | |
| 2022-09-05 17:44:55 -0500 | Rating Details | |
| 2022-09-05 21:06:05 -0500 | Rating Details | |
| 2022-09-05 08:46:59 -0500 | Rating Details | |
| 2022-09-05 11:39:42 -0500 | Rating Details |